Related Products

Summary Of Sabatolimab-API-Small Molecules

Chemical Name

Sabatolimab

CAS No.

2252262-24-9

Molecular Formula

--

Innovator

Developer

Indication

Acute Myeloid Leukemia; Glioblastoma; Myelodysplastic Syndrome

Therapeutic Area

Oncology

Market Status

Investigational

Approval Year

Patent Expiry